ArticleGE Portuguese journal of gastroenterology2025
Five-Year Sustained Response to Nivolumab in Hepatocellular Carcinoma following Serious Immune-Related Hepatitis.
José Leão Mendes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.